Skip to main content

MLabs home

Content type

Utility

Find a Blood Draw Station
Contact Us
MLabsCONNECT

Main navigation

  • Tests
    • Tests
    • Getting Started
    • Forms
    • Requisitions
    • Guidelines & Protocols
    • Submitting a Specimen
    • Order Supplies
    • Explore
    • Specialty Testing
    • Pediatric
    • Genetics
    • Oncology
    • Wet Tissue Biopsy
    • Experts
    • Test Updates
  • Consults
    • Consults
    • Getting Started
    • Request a Consult
    • Explore
    • Experts
    • Sample Reports
  • Resources
    • Resources
    • Results
    • Client Services
    • Billing
    • All Forms
    • Becoming a Client
  • About MLabs
    • About MLabs
    • Quality and Compliance
    • Licensure and Accreditation
    • Facility & Technology
    • News & Events
    • Careers
  • FAQ
    • Patients
    • Providers
  • 800 862-7284
Return to the home page

Breadcrumb

  1. Home
  2. tags
  3. Product Updates

Product Updates

August 18, 2021

Now Performing PD-L1 (22C3) through FDA Approved Therapy Keytruda

MLabs now offers new approved therapy with KEYTRUDA through the PD-L1 (22C3 Assay). KEYTRUDA is a medicine that may treat certain cancers by working with your immune system. This FDA approved companion diagnostic for KEYTRUDA to evaluate triple-negative breast cancer patients.

Product Updates
DDIT3 Rearrangement by FISH
January 20, 2021

New Test: DDIT3 (12q13) Rearrangement by FISH

The detection of DDIT3 rearrangements can be useful in diagnosing myxoid liposarcoma – including uncommon histologic variants – and in distinguishing this sarcoma from other mesenchymal tumors that may be considered in the differential diagnosis.

All News Product Updates
Muscle Biopsy Requirements
November 3, 2020

New Tissue Submission Requirements: Skeletal Muscle Biopsy

In an effort to ensure the safety of our faculty and staff, while maintaining service excellence for our clients and mutual patients, Michigan Medicine Laboratories (MLabs) has updated our tissue submission requirements.

All News Product Updates
Indoor Drive for COVID Testing
October 29, 2020

UPDATED: NEW LOCATION! COVID Drive Through Testing

We have changed our location for COVID testing to an inside drive through to Huron Valley Ambulance Center (HVA).

All News Product Updates
PD-L1 for Breast Cancer
August 11, 2020

Now Offering PD-L1 Testing for Metastatic triple-negative breast cancer (TNBC)

MLabs is now offering PDL-1 testing for Metastatic triple-negative breast cancer (TNBC) whose tumors express PD-L1.

All News Product Updates
New Test NGS Myeloid Panel
June 30, 2020

NOW AVAILABLE: New NGS Myeloid Panel! 

NOW AVAILABLE: NGS Myeloid Panel!  MLabs is excited to announce the addition of our new NGS Myeloid
Panel: For any myeloid or suspected myeloid neoplasm.

All News Product Updates
COVID Serology Testing
June 10, 2020

COVID-19 IgG Serology Testing Now Available!

Serology testing for SARS-CoV-2 is now available for ordering. A separate process for testing and screening of health care workers and Michigan Medicine affiliates will be communicated in the coming weeks. 

All News Product Updates
PIK3CA Mutation for Piqray Woman Cancer
August 14, 2019

MLABS offers NGS to detect PIK3CA mutation targeted by New Metastatic Breast Cancer Treatment

Many patients living with metastatic breast cancer (mBS) now have a new treatment option.

In May 2019, the FDA approved a new targeted therapy, alpelisib (Piqray®). An oral medication intended to be used in combination with fulvestrant (Faslodex®), Piqray® is...

All News Product Updates
NTRK 1 NTRK 2 NTRK 3 Woman patient for Vitrakvi
January 22, 2019

MLabs NGS Panels Detects NTRK Fusion Genes in Select Solid Tumor Patients for FDA-approved Vitrakvi® (larotrectinib) Therapy

MLabs next-generation sequencing (NGS) offerings include Solid Tumor, Lung Cancer, Colorectal Cancer, and Melanoma NGS Panels. These NGS tests target 50 genes to detect substitution and insertion/deletion mutations (35 genes), gene amplifications (19 genes), and gene fusions (21 genes) including NTRK gene fusions...

All News Product Updates
Subscribe to Product Updates

Follow MLabs

Categories

  • Scientific and Clinical Research
  • Product Updates
  • Partnerships and Collaborations
  • General News
  • Events
  • All News

Archives

  • June 2022
  • March 2022
  • February 2022
  • August 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • February 2020
  • October 2019
  • September 2019
  • August 2019
  • June 2019
  • January 2019
  • March 2018
Return to the home page

Footer

  • Tests
  • Consults
  • Resources
  • About MLabs
  • FAQ
Phone: 800 862-7284 | Contact Us
Find a Blood Draw Station
©2022 MLABS A Division of Pathology, Michigan Medicine
Privacy | Terms & Conditions
Client Manual | Physician List

Utility

Find a Blood Draw Station
Contact Us
MLabsCONNECT
Content type

Main navigation

  • Tests
    • Tests
    • Getting Started
    • Forms
    • Requisitions
    • Guidelines & Protocols
    • Submitting a Specimen
    • Order Supplies
    • Explore
    • Specialty Testing
    • Pediatric
    • Genetics
    • Oncology
    • Wet Tissue Biopsy
    • Experts
    • Test Updates
  • Consults
    • Consults
    • Getting Started
    • Request a Consult
    • Explore
    • Experts
    • Sample Reports
  • Resources
    • Resources
    • Results
    • Client Services
    • Billing
    • All Forms
    • Becoming a Client
  • About MLabs
    • About MLabs
    • Quality and Compliance
    • Licensure and Accreditation
    • Facility & Technology
    • News & Events
    • Careers
  • FAQ
    • Patients
    • Providers
  • 800 862-7284